文献速递心血管MR

利用视觉Transformer模型提高心脏磁共振对心脏淀粉样变性的诊断准确性

Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance.
PubMed 文献 · JACC Cardiovasc Imaging · 2024-12-04

本研究基于807例因疑似浸润性疾病或肥厚型心肌病转诊行心脏磁共振的患者,开发并验证了仅使用电影和晚期钆增强图像的视觉Transformer深度学习模型,用于鉴别心脏淀粉样变性。模型在内外部测试集的准确率分别为84.1%和82.8%,AUC分别为0.954和0.957,在人类报告诊断信心不确定的病例中仍具较高准确性。

要点

  • ViT模型仅用电影和LGE图像即可高精度鉴别心脏淀粉样变性。
  • 外部测试集准确率82.8%、AUC 0.957,验证了泛化能力。
  • 在人类报告诊断不确定或错误的病例中,模型仍正确识别61.1%。

核心结论

  • 仅使用电影和晚期钆增强心脏磁共振图像的ViT模型在鉴别心脏淀粉样变性与其它疑似心肌病病因方面达到高准确率,尤其在人类诊断信心不确定的病例中表现突出。

研究设计与样本

  • 回顾性队列研究,开发队列807例(CA 252例、HCM 290例、其他265例),按70/30分为训练集和测试集;外部验证队列157例(CA 51例、HCM 49例、其他57例);参考标准为确诊的最终诊断。

诊断标准与关键数值

  • 内部测试集诊断准确率84.1%,AUC 0.954;外部测试集准确率82.8%,AUC 0.957;在临床报告为中度/高度信心诊断CA的研究中准确率90%(55/61),在报告不确定、缺失或错误诊断CA的研究中准确率61.1%(22/36);去除图像质量差、双重病理或临床显著CA诊断模糊的研究后,该队列深度学习准确率提高至79.1%。

临床应用与阅片要点

  • 模型可辅助鉴别心脏淀粉样变性与肥厚型心肌病等病因,尤其在人类阅片诊断信心不确定时提供参考;原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Cardiac magnetic resonance (CMR) imaging is an important diagnostic tool for diagnosis of cardiac amyloidosis (CA). However, discrimination of CA from other etiologies of myocardial disease can be challenging.

OBJECTIVES: The aim of this study was to develop and rigorously validate a deep learning (DL) algorithm to aid in the discrimination of CA using cine and late gadolinium enhancement CMR imaging.

METHODS: A DL model using a retrospective cohort of 807 patients who were referred for CMR for suspicion of infiltrative disease or hypertrophic cardiomyopathy (HCM) was developed. Confirmed definitive diagnosis was as follows: 252 patients with CA, 290 patients with HCM, and 265 with neither CA or HCM (other). This cohort was split 70/30 into training and test sets. A vision transformer (ViT) model was trained primarily to identify CA. The model was validated in an external cohort of 157 patients also referred for CMR for suspicion of infiltrative disease or HCM (51 CA, 49 HCM, and 57 other).

RESULTS: The ViT model achieved a diagnostic accuracy (84.1%) and an area under the curve of 0.954 in the internal testing data set. The ViT model further demonstrated an accuracy of 82.8% and an area under the curve of 0.957 in the external testing set. The ViT model achieved an accuracy of 90% (n = 55 of 61), among studies with clinical reports with moderate/high confidence diagnosis of CA, and 61.1% (n = 22 of 36) among studies with reported uncertain, missing, or incorrect diagnosis of CA in the internal cohort. DL accuracy of this cohort increased to 79.1% when studies with poor image quality, dual pathologies, or ambiguity of clinically significant CA diagnosis were removed.

CONCLUSIONS: A ViT model using only cine and late gadolinium enhancement CMR images can achieve high accuracy in differentiating CA from other underlying etiologies of suspected cardiomyopathy, especially in cases when reported human diagnostic confidence was uncertain in both a large single state health system and in an external CA cohort.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Cockrum J, Nakashima M, Ammoury C, et al. Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2024. PMID: 39641685. doi:10.1016/j.jcmg.2024.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。